Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality | Thorax
The only randomised controlled survival study in PAH is the original intravenous epoprostenol study.28 For similar practical ... A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension ...